IC
DGX icon

IEQ Capital’s Quest Diagnostics DGX Stock Holding History

IEQ Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,899
Closed -$1.19M – 1642
2024
Q4 		$1.19M Sell
7,899
-1,099
-12% -$171K 0.01% 618
2024
Q3 		$1.4M Buy
8,998
+1,568
+21% +$234K 0.02% 453
2024
Q2 		$1.02M Buy
7,430
+2,269
+44% +$311K 0.01% 468
2024
Q1 		$687K Buy
5,161
+1,602
+45% +$208K 0.01% 541
2023
Q4 		$491K Buy
3,559
+822
+30% +$108K 0.01% 582
2023
Q3 		$334K Buy
2,737
+455
+20% +$60.6K 0.01% 693
2023
Q2 		$321K Buy
2,282
+302
+15% +$41.6K 0.01% 652
2023
Q1 		$280K Buy
1,980
+506
+34% +$72.4K 0.01% 738
2022
Q4 		$231K Sell
1,474
-655
-31% -$94.1K 0.01% 704
2022
Q3 		$261K Buy
2,129
+303
+17% +$39.9K 0.01% 701
2022
Q2 		$243K Buy
1,826
+168
+10% +$22.9K 0.01% 663
2022
Q1 		$227K Sell
1,658
-146
-8% -$20.4K 0.01% 722
2021
Q4 		$312K Buy
1,804
+157
+10% +$23.9K 0.01% 578
2021
Q3 		$239K Buy
+1,647
New +$241K 0.01% 620

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

IEQ Capital's DGX Position: Q1 2025 in Review

IEQ Capital sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 7,899 shares — an estimated $1.19M sold.

IEQ Capital first reported a position in DGX in Q3 2021 and held it in 14 quarters. The position peaked at $1.4M in Q3 2024. 967 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

  • IEQ Capital reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
  • IEQ Capital sold 7,899 Quest Diagnostics shares in Q1 2025, an estimated $1.19M.
  • IEQ Capital first reported a position in Quest Diagnostics in Q3 2021 and held it in 14 quarters.
  • IEQ Capital's Quest Diagnostics position peaked at $1.4M in Q3 2024.
  • 967 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on IEQ Capital's 13F filing for Q1 2025, filed 14 May 2025.